Curevac to report third quarter and first nine months 2024 financial results and business update on november 12, 2024

TÜbingen, germany and boston, ma / accesswire / november 7, 2024 / curevac n.v. (nasdaq:cvac) ("curevac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mrna"), will report financial results, and provide business updates for the third quarter and first nine months 2024 on tuesday, november 12, 2024.
CVAC Ratings Summary
CVAC Quant Ranking